Schrödinger, Inc.

NASDAQ:SDGR

Medical - Healthcare Information Services

Healthcare
$27.20 +0.01%

+$0.00 today

Market cap
$1.79B
Beta
1.64
P/E (TTM)
-11.1
EPS (TTM)
-$1.40
52W Low $10.95High $23.75

Volume 1.18M

Average 1.35M

SDGR EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

Schrödinger, Inc.NASDAQ: SDGR

EPS (Diluted) · Q3 FY2026 · quarter ended Sep 2026

EPS (Diluted) remains negative

Q3 FY2026 EPS (Diluted) was -$0.5, compared with -$0.45 a year earlier. Trailing-twelve-month EPS (Diluted) was -$0.79.

Context

  • EPS (Diluted) increased in 2 of the last 3 fiscal years.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 3 analysts of -$1.47 (-4.5%) for the fiscal year ending Dec 2026, a slowdown from the +45.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
-$0.5-725.0% QoQ
Last fiscal yearDec 2025
-$1.41+45.1% YoY
LTMSep 2026
-$0.79+67.2% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-11.1%-158.0%-146.9 pp
1 year+45.1%-4.5%-49.6 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

USD · from the income statement

Latest · FY2025
(1.41) USD
Year-over-year change
+45.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How SDGR compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Diluted) is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +67.2% is the 2nd highest of 9, against a peer median of +18.4%.
SDGR Competitors
EPS (Diluted) for SDGR and competitors
Company Period LTM YoY 3-year CAGR
VEEVVeeva Systems Inc.LTM Jul 2026$6.08 USD+25.1%+21.9%
CERTCertara, Inc.LTM Mar 2026-$0.1 USD-505.1%—
HYFTMindWalk Holdings Corp.LTM Jan 2026-CA$0.29 CAD+81.9%—
ABCLAbCellera Biologics Inc.LTM Sep 2026-$0.48 USD+17.2%—
SDGRSchrödinger, Inc.LTM Sep 2026-$0.79 USD+67.2%—
LTRNLantern Pharma Inc.LTM Mar 2026-$1.45 USD+21.2%—
RLAYRelay Therapeutics, Inc.LTM Jun 2026-$1.57 USD+19.5%—
SLPSimulations Plus, Inc.LTM Feb 2026-$3.13 USD-988.8%—
GENBGenerate Biomedicines, Inc.FY2025-$4.98 USD-196.4%—
Peer median (excluding SDGR) —+18.4%+21.9%

Competitors are the stored peer set for SDGR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue137.93M180.96M216.67M207.54M255.87M
Cost of Revenue72.31M79.93M75.97M75.46M113.26M
Gross Profit65.62M101.02M140.69M132.08M142.61M
Gross Margin47.6%55.8%64.9%63.6%55.7%
Research & Development90.9M126.37M181.77M201.79M173.14M
Selling, General & Admin86.16M121.47M136.37M139.59M136.37M
Operating Expenses177.06M247.84M318.14M341.38M309.51M
Depreciation & Amortization2.85M4.34M5.55M6.16M6.02M
EBITDA(97.96M)(144.78M)48.47M(179.55M)(96.3M)
EBITDA Margin-71.0%-80.0%22.4%-86.5%-37.6%
Operating Income(111.44M)(146.82M)(177.45M)(209.3M)(166.9M)
Operating Margin-80.8%-81.1%-81.9%-100.8%-65.2%
Interest Income1.06M3.95M000
Interest Expense03K000
Other Income / Expenses10.64M(2.31M)220.37M23.59M64.57M
Income Before Tax(100.81M)(149.12M)42.92M(185.71M)(102.33M)
Pre-Tax Margin-73.1%-82.4%19.8%-89.5%-40.0%
Income Tax Expense411K63K2.2M1.41M939K
Net Income(100.39M)(149.19M)40.72M(187.12M)(103.27M)
Net Margin-72.8%-82.4%18.8%-90.2%-40.4%
EPS (Basic)(1.43)(2.10)0.57(2.57)(1.41)
EPS (Diluted)(1.43)(2.10)0.54(2.57)(1.41)
Weighted Avg Shares70.59M71.17M71.78M72.67M73.44M
Weighted Avg Shares (Diluted)70.59M71.17M74.99M72.67M73.44M

Schrödinger, Inc.

NASDAQ:SDGR

Intrinsic Alpha fair value

Locked

Current Price

$27.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.